Autoantibodies against β1 Receptor and AT1 Receptor in Type 2 Diabetes Patients with Left Ventricular Dilatation

Publisher： Karger

E-ISSN： 1421-9751|129|3|191-196

ISSN： 0008-6312

Source： Cardiology, Vol.129, Iss.3, 2014-10, pp. : 191-196

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Autoantibodies in Type 2 Diabetes Patients with Left Ventricular Dilatation: Biomarkers and/or Risk Markers?

By  

Cardiology, Vol. 129, Iss. 3, 2014-10 ,pp. : 189-190

Karger

Access to resources Recommend Favorite

Aortic Elastic Properties Are Related to Left Ventricular Diastolic Function in Patients with Type 1 Diabetes Mellitus

By  

Cardiology, Vol. 109, Iss. 2, 2007-08 ,pp. : 99-104

Karger

Access to resources Recommend Favorite

Early use of glucagon-like peptide-1 receptor agonists (GLP-1 RAs) in Type 2 diabetes

By Ross Stuart A.   Ballantine Jane  

Current Medical Research and Opinion, Vol. 29, Iss. 12, 2013-12 ,pp. : 1617-1626

Informa Healthcare

Access to resources Recommend Favorite

Characterization of the autoimmune response against the nerve tissue S100β in patients with type 1 diabetes

By  

CLINICAL & EXPERIMENTAL IMMUNOLOGY, Vol. 180, Iss. 2, 2015-05 ,pp. : 207-217

John Wiley & Sons Inc

Access to resources Recommend Favorite

Soluble urokinase plasminogen activator receptor levels are elevated and associated with complications in patients with type 1 diabetes

By  

JOURNAL OF INTERNAL MEDICINE, Vol. 277, Iss. 3, 2015-03 ,pp. : 362-371

John Wiley & Sons Inc

Access to resources Recommend Favorite